DarylTLauMDMPH
Gastroenterology • Boston, MAHepatology & Liver Transplantation
Associate Professor of Medicine, Harvard Medical School
Dr. Lau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 Francis St
Ste 4A
Boston, MA 02215Phone+1 617-632-1098Fax+1 617-632-1093
Education & Training
McGill University Faculty of MedicineClass of 1986
Johns Hopkins UniversityMPH, Public Health
Certifications & Licensure
MA State Medical License 2006 - 2025
TX State Medical License 1999 - 2007
Clinical Trials
- Hepatitis B Research Network Adult Cohort Study Start of enrollment: 2010 Dec 01
- HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B Start of enrollment: 2011 Feb 01
- Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 203 citationsEvaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW. Ray Kim, Thomas Berg, Tarik Asselah, Robert Flisiak, Scott Fung
Journal of Hepatology. 2016-04-01 - 329 citationsViral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infectionYueh Ming Loo, David M. Owen, Kui Li, Andrea K. Erickson, Cynthia L. Johnson
Proceedings of the National Academy of Sciences of the United States of America. 2006-04-11 - 37 citationsCurrent Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in HarmonyShailaja Jamma, Ghazi Hussain, Daryl T.-Y. Lau
Current Hepatitis Reports. 2010-09-03
Press Mentions
Market Wrap: Bitcoin Traders Expect Big Move as Volatility PlummetsJune 29th, 2020
Improved Definition of HBV Phenotypes Based on Genotype-Specific Levels of Hepatitis B S AntigenDecember 27th, 2018
Grant Support
- Clinical Core And Data Coordination CenterNational Institute Of Allergy And Infectious Diseases2010–2012
- Harvard Hepatitis B ConsortiumNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Racial Differences In IFN Transcriptional ResponseNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2009
- Racial Differences In IFN Transcriptional ResponseNational Center For Research Resources2008
- Comparing The Response Rate Of An Accelerated Vaccination Schedule Using ANational Center For Research Resources2004–2007
- Pathogenesis Of Insulin Resistance And Hepatic Steatosis In Patients WithNational Center For Research Resources2006
- Racial Differences In IFN Transcriptional ResponseNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Racial Prevalence And Clinicopathological Evaluation Of Non-AlcoholicNational Center For Research Resources2004
- Dose-Ranging Study Of Viramidine In Combination With Pegasys In Treatment-NaiveNational Center For Research Resources2004
- A Rising Multiple-Dose Study To Evaluate Safety, Tolerability, AndNational Center For Research Resources2004
- A Double-Blind, Placebo-Controlled Rising Multiple-Dose Study To Evaluate SafetyNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
